REBRIDEN

Welcome to the Brand page for “REBRIDEN”, which is offered here for Pharmaceutical preparation for use in the treatment of hypertension, angina and congestive heart failure;.

Its status is currently believed to be active. Its class is unavailable. “REBRIDEN” is believed to be currently owned by “SANDOZ PHARMACEUTICALS CORPORATION”.

Owner:
SANDOZ PHARMACEUTICALS CORPORATION
Owner Details
Description:
PHARMACEUTICAL PREPARATION FOR USE IN THE TREATMENT OF HYPERTENSION, ANGINA AND CONGESTIVE HEART FAILURE;
Categories: PHARMACEUTICAL PREPARATION FOR USE IN